Clearstead Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.6K | Buy |
1,003
+3
| +0.3% | +$65 | ﹤0.01% | 1583 |
|
|
2025
Q1 | $16.6K | Hold |
1,000
| – | – | ﹤0.01% | 1469 |
|
|
2024
Q4 | $18.4K | Hold |
1,000
| – | – | ﹤0.01% | 1412 |
|
|
2024
Q3 | $15.4K | Hold |
1,000
| – | – | ﹤0.01% | 1492 |
|
|
2024
Q2 | $16.3K | Hold |
1,000
| – | – | ﹤0.01% | 1435 |
|
|
2024
Q1 | $15.2K | Hold |
1,000
| – | – | ﹤0.01% | 988 |
|
|
2023
Q4 | $31.3K | Sell |
1,000
-1,000
| -50% | -$31.3K | ﹤0.01% | 855 |
|
|
2023
Q3 | $41.7K | Buy |
2,000
+1,000
| +100% | +$20.8K | ﹤0.01% | 911 |
|
|
2023
Q2 | $24K | Hold |
1,000
| – | – | ﹤0.01% | 871 |
|
|
2023
Q1 | $18.8K | Hold |
1,000
| – | – | ﹤0.01% | 862 |
|
|
2022
Q4 | $15.9K | Hold |
1,000
| – | – | ﹤0.01% | 835 |
|
|
2022
Q3 | $16K | Hold |
1,000
| – | – | ﹤0.01% | 803 |
|
|
2022
Q2 | $14K | Hold |
1,000
| – | – | ﹤0.01% | 862 |
|
|
2022
Q1 | $24K | Hold |
1,000
| – | – | ﹤0.01% | 818 |
|
|
2021
Q4 | $23K | Sell |
1,000
-508
| -34% | -$11.7K | ﹤0.01% | 786 |
|
|
2021
Q3 | $25K | Hold |
1,508
| – | – | ﹤0.01% | 736 |
|
|
2021
Q2 | $37K | Hold |
1,508
| – | – | ﹤0.01% | 600 |
|
|
2021
Q1 | $39K | Hold |
1,508
| – | – | ﹤0.01% | 578 |
|
|
2020
Q4 | $81K | Hold |
1,508
| – | – | 0.01% | 448 |
|
|
2020
Q3 | $62K | Buy |
1,508
+1,008
| +202% | +$41.4K | 0.01% | 435 |
|
|
2020
Q2 | $24K | Hold |
500
| – | – | ﹤0.01% | 509 |
|
|
2020
Q1 | $21K | Buy |
+500
| New | +$21K | ﹤0.01% | 497 |
|